HLTHQ — Cue Health Share Price
- $0.00m
- -$79.73m
- $70.94m
- 13
- 82
- 28
- 36
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0 | ||
Price to Tang. Book | 0 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -126.19% | ||
Return on Equity | -90.35% | ||
Operating Margin | -527.11% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 6.63 | 22.95 | 618.11 | 483.48 | 70.94 | 61.35 | 111.63 | 80.89% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Cue Health Inc. is a healthcare technology company. The Company uses diagnostic-enabled care to enable people to live their healthiest lives. Its proprietary platform, the Cue Integrated Care Platform, which is comprised of its Cue Health Monitoring System, Cue Data and Innovation Layer, Cue Virtual Care Delivery Apps, Cue Ecosystem Integrations and Apps, and access to additional Cue-branded and third-party diagnostic products, enables lab-quality diagnostics-led care at home, at work or at the point of care. Its platform offers individuals and healthcare providers convenient and personalized access to lab-quality diagnostic tests at home and at the point-of-care, as well as on-demand telehealth consultations and treatment options for a range of health and wellness needs. The Cue Health Monitoring System is designed to deliver a menu of tests through one system, enabling two testing modalities, nucleic acid amplification and immunoassays, in one device.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- January 1st, 2010
- Public Since
- September 24th, 2021
- No. of Shareholders
- 43
- No. of Employees
- 726
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
Pink Sheets on Nasdaq
- Shares in Issue
- 159,091,814

- Address
- 4980 Carroll Canyon Road, Suite 100, SAN DIEGO, 92121
- Web
- https://cuehealth.com/
- Phone
- +1 8584128151
- Auditors
- BDO USA, LLP
Upcoming Events for HLTHQ
Similar to HLTHQ
1606
Pink Sheets on Nasdaq
Ablaze Technologies
Pink Sheets on Nasdaq
Accelerated Technologies Holding
Pink Sheets on Nasdaq
Acorn Energy
Pink Sheets on Nasdaq
Advantego
Pink Sheets on Nasdaq
FAQ
As of Today at 02:07 UTC, shares in Cue Health are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in Cue Health last closed at $0.00 and the price had moved by -100% over the past 365 days. In terms of relative price strength the Cue Health share price has underperformed the S&P500 Index by -100% over the past year.
The overall consensus recommendation for Cue Health is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreCue Health does not currently pay a dividend.
Cue Health does not currently pay a dividend.
Cue Health does not currently pay a dividend.
To buy shares in Cue Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in Cue Health had a market capitalisation of $0.00m.
Here are the trading details for Cue Health:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: HLTHQ
Based on an overall assessment of its quality, value and momentum Cue Health is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Cue Health is $0.50. That is 49999900% above the last closing price of $0.00.
Analysts covering Cue Health currently have a consensus Earnings Per Share (EPS) forecast of -$0.84 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cue Health. Over the past six months, its share price has outperformed the S&P500 Index by +3.51%.
As of the last closing price of $0.00, shares in Cue Health were trading -100% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Cue Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Cue Health's directors